Loading clinical trials...
Loading clinical trials...
A Randomized, Multicenter Open Label Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis
Conditions
Interventions
CYCLOSPORINE VS INFLIXIMAB
Locations
41
Belgium
Hopital Erasme
Brussels, Belgium
Ulb - Clinique Saint Luc
Brussels, Belgium
Gent University Hospital
Ghent, Belgium
Leuven University Hospital
Leuven, Belgium
Helsinki University Hospital
Helsinki, Finland
Chu Amiens
Amiens, France
Start Date
June 1, 2007
Primary Completion Date
June 1, 2007
Completion Date
October 1, 2010
Last Updated
August 31, 2011
NCT07271069
NCT06975722
NCT07185009
NCT07184996
NCT07245394
NCT07089420
Lead Sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions